Obesity and thrombotic risk

  title={Obesity and thrombotic risk},
  author={Susanna Colli and Cesare R. Sirtori},
  journal={British Journal of Nutrition},
  pages={1731 - 1732}
  • S. ColliC. Sirtori
  • Published 1 December 2010
  • Biology, Medicine
  • British Journal of Nutrition
The link between obesity and thrombotic risk represents an important issue since the prevalence of obesity in adults has increased rapidly in the last decades, especially in Western countries although this is an emerging health issue elsewhere too. Estimates from the WHO indicate that globally there are more than 300 million obese adults. From a physiological point of view, adipose tissue is the major site of storage of TAG. An increase in adipose tissue mass, however, often triggers… 
4 Citations

Thromboembolic disorders in obstetrics.

Approach to permanent hemodialysis access in obese patients.

  • R. Feezor
  • Medicine, Biology
    Seminars in vascular surgery
  • 2011
In this review, the outcomes associated with permanent hemodialysis access in the obese are discussed and helpful suggestions to facilitate a functional access provided.

Best Practice & Research Clinical Obstetrics and Gynaecology

Magnesium is a moderate tocolytic but the evidence for its effectiveness remains disputed, and it should be administered to all patients with severe pre-eclampsia or eClampsia.



Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk?

The presence of TF‐expressing MN in blood from obese subjects and the in vitro induction of TF by pharmacologic concentrations of leptin in MN from healthy subjects suggest that TF expression by leptin‐stimulated monocytes may contribute to the cardiovascular risk associated with obesity.

Fibrin(ogen) in cardiovascular disease: an update.

  • W. Koenig
  • Biology, Medicine
    Thrombosis and haemostasis
  • 2003
Whether or not fibrinogen is causally involved in atherothrombogenesis still remains to be determined, and even though other unsolved issues await conclusive answers, fibr inogen has emerged as an important additional marker of cardiovascular risk.

Obesity, haemostasis and the fibrinolytic system

  • I. MertensL. Gaal
  • Medicine, Biology
    Obesity reviews : an official journal of the International Association for the Study of Obesity
  • 2002
The increased cardiovascular risk observed in obesity could in part be explained by the association between insulin resistance and components of the fibrinolytic and haemostatic systems.

Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation

It is shown that adipose tissue of obese mice is hypoxic and that local adipose tissues hypoxia dysregulates the production of adipocytokines, and the results suggest that hypoperfusion and Hypoxia in adipose organs underlie the dysregulated production of fat-derived secretory factors and metabolic syndrome in obesity.

Tumor necrosis factor α is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1

In obese (ob/ob) mice, neutralization of TNF-α or deletion of both TNF receptors (TNFRs) results in significantly reduced levels of plasma PAI-1 antigen, plasma insulin, and adipose tissue PAi-1 and TGF-β mRNAs.

Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans

The data suggest that visceral fat is an important site for IL-6 secretion and provide a potential mechanistic link between visceral fat and systemic inflammation in people with abdominal obesity.

Tissue factor in atherosclerosis.

Regulation of tissue factor gene expression in obesity.

The hyperinsulinemia associated with insulin-resistant states, such as obesity and noninsulin-dependent diabetes mellitus, may induce local TF gene expression in multiple tissues, and the elevated TF may contribute to the increased risk of atherothrombotic disease that accompanies these conditions.

Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS)

It is shown, for the first time, in a large prospective study that leptin is a novel, independent risk factor for coronary heart disease.

Overweight, obesity, and the risk of recurrent venous thromboembolism.

Excess body weight is a risk factor of recurrent venous thromboembolism and was significantly higher among patients with recurrence than among those without recurrence.